Literature DB >> 16551791

Growth hormone and respiratory compromise in Prader-Willi Syndrome.

S S I Wilson1, A M Cotterill, M-A Harris.   

Abstract

Recombinant human growth hormone (rhGH) therapy in Prader-Willi syndrome (PWS) causes increased basal metabolic rate and oxygen consumption, and hence increased ventilatory load. The case of an adolescent with PWS who experienced respiratory deterioration with an increase in rhGH and improvement with cessation of therapy is reported.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16551791      PMCID： PMC2065960          DOI： 10.1136/adc.2005.086090

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  9 in total

1.  Increased mortality associated with growth hormone treatment in critically ill adults.

Authors:  J Takala; E Ruokonen; N R Webster; M S Nielsen; D F Zandstra; G Vundelinckx; C J Hinds
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

Review 2.  Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

Authors:  P Burman; E M Ritzén; A C Lindgren
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

3.  Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report.

Authors:  Urs Eiholzer; Yves Nordmann; Dagmar L'Allemand
Journal:  Horm Res       Date:  2002

4.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study.

Authors:  L Burdet; B de Muralt; Y Schutz; C Pichard; J W Fitting
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

Review 5.  Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS.

Authors:  Urs Eiholzer
Journal:  Horm Res       Date:  2004-12-13

6.  Sudden death of an infant with Prader-Willi syndrome--not a unique case?

Authors:  Yves Nordmann; Urs Eiholzer; Dagmar l'Allemand; Slavko Mirjanic; Christoph Markwalder
Journal:  Biol Neonate       Date:  2002-08

Review 7.  Sleep and breathing in Prader-Willi syndrome.

Authors:  Gillian M Nixon; Robert T Brouillette
Journal:  Pediatr Pulmonol       Date:  2002-09

8.  Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.

Authors:  Andrea M Haqq; Diane D Stadler; Russell H Jackson; Ron G Rosenfeld; Jonathan Q Purnell; Stephen H LaFranchi
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

Review 9.  Sudden death in growth hormone-treated children with Prader-Willi syndrome.

Authors:  Guy Van Vliet; Cheri L Deal; Patricia A Crock; Yves Robitaille; Luc L Oligny
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406
  9 in total
  1 in total

1.  Systematic review of the clinical and genetic aspects of Prader-Willi syndrome.

Authors:  Dong Kyu Jin
Journal:  Korean J Pediatr       Date:  2011-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.